Results 151 to 160 of about 3,780 (219)

[L-dopa and antiparkinson agents].

Revue medicale de Liege, 1996
Delwaide Pj
openalex   +2 more sources

Antiparkinson agent/Quetiapine/Sertraline

Reactions Weekly

openalex   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Quantitative Determination of Some Synthetic Antiparkinsonism Agents

Journal of Pharmaceutical Sciences, 1968
Nonaqueous titrimetry was employed to estimate quantitatively some of the compounds which are useful in treating Parkinsonism. The method was applied to both the crystalline material and their dosage forms. This technique was found to yield results which agreed well with those obtained by either the official procedures or by methods submitted by the ...
L G, Chatten, W J, Racz
openaire   +2 more sources

Reactions to Antiparkinson Agents

1987
The cardiovascular effects are dose-related. Low doses can cause transient bradycardia; moderate or high doses can cause tachycardia, palpitation, and arrhythmias (due to blockage of vagal effects on the S-A node).
Frank L. Tornatore, John J. Sramek, Bette L. Okeya, Edmond H. Pi   +3 more
openaire   +1 more source

[Drug information: antiparkinson agents. II. Dopaminergic agents].

Sygeplejersken, 1981
Veje Jo
openalex   +2 more sources

Therapeutic Antagonism between Anticholinergic Antiparkinsonism Agents and Neuroleptics in Schizophrenia

Neuropsychobiology, 1979
Mohan Singh, Stanley R. Kay
openalex   +2 more sources

Some New Piperazino Derivatives as Antiparkinson and Anticonvulsant Agents

Archiv der Pharmazie, 1983
AbstractThe piperazino derivatives 1–7 were synthesized and evaluated for their antiparkinson activity on oxotremorine‐induced tremors and reserpine‐induced rigidity. The same compounds were screened for their anticonvulsant activity. Compounds 1, 3, 4 and 5 showed promising antiparkinson activity.
J C, Agarwal, C, Nath, M, Sharma, G P, Gupta, K P, Bhargava, K, Shanker   +5 more
openaire   +2 more sources

Metabolism of antiparkinson agent dopazinol by rat liver microsomes.

Drug Metabolism and Disposition, 1990
Metabolism of dopazinol (DZ) by liver microsomes from control and phenobarbital- and 3-methylcholanthrene-treated rats has been investigated. Liver microsomes from control and treated rats metabolized DZ to N-despropyl-DZ (39-53% of total metabolites); 8-hydroxy-DZ, a catechol metabolite (32-39%); and 5- or 6-hydroxy-DZ (12-20%).
K P, Vyas, P H, Kari, H G, Ramjit, S M, Pitzenberger, M, Hichens   +4 more
openaire   +2 more sources

[Considerations on projected pharmacology of antiparkinson agents].

Therapie, 1969
P Duchêne-Marullaz, M Jalfre, J Hache
openalex   +2 more sources

Potential antiparkinsonism agents. Quinuclidinyl benzhydryl ethers

Journal of Medicinal Chemistry, 1969
J L, Nilsson, J, Wågermark, R, Dahlbom
openaire   +2 more sources